Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
grade D 26.78 0.15% 0.04
INSM closed up 0.15 percent on Wednesday, August 5, 2020, on 74 percent of normal volume. It ran into resistance at its 50 day moving average.
Earnings due: Aug 6
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical INSM trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Fell Below 20 DMA Bearish 0.15%
Fell Below 50 DMA Bearish 0.15%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.15%
MACD Bullish Signal Line Cross Bullish 0.15%
Bollinger Band Squeeze Range Contraction 0.15%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
Biopharmaceutical Medical Specialties Infectious Diseases Cystic Fibrosis Infectious Causes Of Cancer Microbiology Bacterial Diseases Tuberculosis Bacteriology Pseudomonas Mycobacterium Nontuberculous Mycobacteria

Is INSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.94
52 Week Low 12.09
Average Volume 852,205
200-Day Moving Average 23.51
50-Day Moving Average 27.09
20-Day Moving Average 26.70
10-Day Moving Average 26.50
Average True Range 1.20
ADX 14.97
+DI 14.60
-DI 17.70
Chandelier Exit (Long, 3 ATRs ) 25.34
Chandelier Exit (Short, 3 ATRs ) 28.80
Upper Bollinger Band 27.82
Lower Bollinger Band 25.58
Percent B (%b) 0.54
BandWidth 8.38
MACD Line -0.13
MACD Signal Line -0.15
MACD Histogram 0.0181
Fundamentals Value
Market Cap 1.67 Billion
Num Shares 62.4 Million
EPS -3.04
Price-to-Earnings (P/E) Ratio -8.81
Price-to-Sales 0.00
Price-to-Book 20.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.20
Resistance 3 (R3) 28.23 27.79 27.96
Resistance 2 (R2) 27.79 27.43 27.77 27.88
Resistance 1 (R1) 27.28 27.20 27.06 27.25 27.80
Pivot Point 26.84 26.84 26.73 26.83 26.84
Support 1 (S1) 26.34 26.48 26.12 26.31 25.76
Support 2 (S2) 25.90 26.26 25.88 25.68
Support 3 (S3) 25.39 25.90 25.60
Support 4 (S4) 25.36